首页> 美国卫生研究院文献>other >Developing a Common Language for Tumor Response to Immunotherapy: Immune-related Response Criteria using Unidimentional measurements

【2h】

Developing a Common Language for Tumor Response to Immunotherapy: Immune-related Response Criteria using Unidimentional measurements

机译：开发一种针对免疫疗法的肿瘤反应的通用语言：使用基本测量法的免疫相关反应标准

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

PurposeImmune-related response criteria (irRC) was developed to adequately assess tumor response to immunotherapy. The irRC are based on bidimensional measurements, as opposed to unidimensional measurements defined by RECIST, which has been widely used in solid tumors. We aimed to compare response assessment by bidimensional versus unidimensional irRC in advanced melanoma patients treated with ipilimumab.

机译：目的制定免疫相关反应标准（irRC）以充分评估肿瘤对免疫治疗的反应。 irRC基于二维测量，与RECIST定义的一维测量相反，RECIST已广泛用于实体瘤。我们的目的是比较依普利单抗治疗的晚期黑色素瘤患者通过二维和单维irRC进行的反应评估。

著录项

期刊名称 other
作者
Mizuki Nishino; Anita Giobbie-Hurder; Maria Gargano; Margaret Suda; Nikhil H. Ramaiya; F. Stephen Hodi;
展开▼
作者单位

展开▼
年(卷),期 -1(19),14
年度 -1
页码 3936–3943
总页数 17
原文格式 PDF
正文语种
中图分类
关键词
melanoma immunotherapy tumor response tumor measurements immune-related response criteria;

机译：黑色素瘤;免疫疗法;肿瘤反应;肿瘤测量;免疫相关反应标准;

相似文献

外文文献
中文文献
专利

1. Developing a common language for tumor response to immunotherapy: Immune-related response criteria using unidimensional measurements [J] . NishinoM., Giobbie-HurderA., GarganoM., Clinical cancer research: an official journal of the American Association for Cancer Research . 2013,第14期

机译：开发一种针对肿瘤对免疫治疗反应的通用语言：使用一维测量的免疫相关反应标准
2. Concordance between the response evaluation criteria in solid tumors version 1.1 and the immune-related response criteria in patients with non-small cell lung cancer treated with nivolumab: a multicenter retrospective cohort study [J] . Yuki Kataoka, Katsuya Hirano, Tomoko Narabayashi, Cancer chemotherapy and pharmacology. . 2018,第2期

机译：实体肿瘤版本1.1中的响应评估标准之间的一致性和用Nivolumab处理的非小细胞肺癌患者的免疫相关响应标准：多中心回顾性队列研究
3. Concordance between the response evaluation criteria in solid tumors version 1.1 and the immune-related response criteria in patients with non-small cell lung cancer treated with nivolumab: a multicenter retrospective cohort study [J] . Yuki Kataoka, Katsuya Hirano, Tomoko Narabayashi, Cancer chemotherapy and pharmacology. . 2018,第2期

机译：用Nivolumab处理的非小细胞肺癌患者的响应评估标准与实体瘤中的响应评估标准的一致性：多中心回顾性队列研究
4. Synergistically Transcutaneous Immunotherapy Enhances Antitumor Immune Responses through Blockade of PD1 and IDO [C] . Yanqi Ye, Jinqiang Wang, Quanyin Hu, Society for Biomaterials annual meeting and exposition . 2017

机译：协同经皮免疫疗法可通过阻断PD1和IDO增强抗肿瘤免疫反应
5. Understanding the Role of the Tumor Microenvironment on Disease Metastasis, Progression, and Response to Immunotherapy Using Transcriptomics [D] . Kamal, Yasmin. 2020

机译：了解肿瘤微环境对疾病转移，进展和使用转录组织的免疫疗法的作用
6. Immune-related response evaluations during immune-checkpoint inhibitor therapy: establishing a common language for the new arena of cancer treatment [O] . Mizuki Nishino 2016

机译：免疫检查点抑制剂治疗期间的免疫相关反应评估：为癌症治疗的新领域建立通用语言
7. Developing a Common Language for Tumor Response to Immunotherapy: Immune-Related Response Criteria Using Unidimensional Measurements [O] . Mizuki Nishino, Anita Giobbie-Hurder, Maria Gargano, 2013

机译：开发肿瘤反应的常规语言对免疫疗法：使用单向测量的免疫相关响应标准

Developing a Common Language for Tumor Response to Immunotherapy: Immune-related Response Criteria using Unidimentional measurements

摘要

著录项

相似文献

相关主题

期刊订阅